Plasma nitrite/nitrate concentrations in patients with schizophrenia

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 1, 2010, Pages 89-94

  Djordjević, Vladimir V ^a   Stojanović, Ivana ^b   Stanković Ferlež, Dragana ^a   Ristić, Tatjana ^a   Lazarević, Dušan ^a   Ćosić, Vladan ^a   Djordjević, Vidosava B ^b  

^a Clinical Centre Nis   (Serbia)

^b Faculty of Medicine   (Serbia)

Author keywords

Caspase 3 activity; Nitrite nitrate; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CASPASE 3; HALOPERIDOL; NITRATE; NITRITE;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ENZYME ACTIVITY; FEMALE; HEREDITY; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; SMOKING;

ADULT; CASPASE 3; FEMALE; HUMANS; MALE; NITRATES; NITRIC OXIDE; NITRITES; SCHIZOPHRENIA; SEX FACTORS;

EID: 74549195553     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.014     Document Type: Article

References (36)

1. Rettori V, Fernandez-Solari J, Mohn C, Zubilete MA, de la Cal C, Prestifilippo JP, et al. Nitric oxide at the crossroad of immunoneuroendocrine interactions. Ann NY Acad Sci 2009;1153: 35-47.
2. Lee J, Ryn H, Ferrante RJ, Morris SM, Ratan RR. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Neuroscience 2003;100: 4843-4848
3. Kazuo K, Hirata Y, Imai T, Iwashina M, Marumo F. Regulation of inducible nitric oxide synthase gene by interleukin-1b in rat vascular endothelial cells. Am J Physiol 1994;267:H2318-24.
4. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res 1994;31:131-143
5. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
6. Djordjević BV, Stojanović I,Ćosić V, Zvezdanović L, Deljanin-Ilić M, Dimić S, et al. Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-a levels in patients with ischemic heart disease. Clin Chem Lab Med 2008;46:1149-1155
7. Kalinichenko SG, Matveeva NY. Morphological characteristics of apoptosis and its significance in neurogenesis. Neurosci Behav Physiol 2008;38:333-344
8. Wass C. Cognition and social behaviour in schizophrenia: an animal model investigating the potential role of nitric oxide. Doctoral dissertation. Sahlgrenska Academy, Goteborg University, Sweden, 2007.
9. Yanik M, Vural H, Kocyigit A, Tutkun H, Zoroglu SS, Herken H, et al. Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiol 2003;47:61-65
10. Navaro-Gonzalvez JA, Garcia-Benayas M, Arenas I. Semiautomated measurement of nitrate in biological fluids. Clin Chem 1998;44:679-681
11. Peinado MA, Lopez-Ramos JC, Camacho MV, Molina FJ, Martinez- Romero R, Hernandez R, et al. Age and sex-related serum changes in nitric oxide: correlation with serological markers. Int J Cardiol 2007;121:88-90.
12. Ghasemi A, Asl ZS, Mehrabi Y, Saadat N, Azizi F. Serum nitric oxide metabolite levels in a general healthy population: relation to sex and age. Life Sci 2008;83:326-331
13. Lars R, Torstein L, Trude A, Kare B. A twin study of nitric oxide levels measured by serum nitrite/nitrate. Twin Res Hum Gen 2006;9:210-214
14. Sarkar R, Gelabert HA, Mohiuddin KR, Thakor DK, Santibanez-Gallerani AS. Effect of cigarette smoke on endothelial regeneration in vivo and nitric oxide levels. J Surg Res 1999;82:43-47
15. Aksoy H, Aksoy Y, Akcay F, Kurtul N. Estradiol and nitric oxide in men over 50 years of age. Int Urol Nephrol 2000; 32:81-83
16. Hideaki H, Hirohisa M, Hidenori M, Yoshihisa M. Serum nitric oxide metabolite (NOx) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls. Clin Exp Pharmacol Physiol 2007;34:725-731
17. Kanabrocki EL, George M, Hermida RC, Messmore HL, Ryan MD, Ayala DE, et al. Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectin. Clin Appl Thromb Hemost 2001;7:339-345
18. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999;33:652-658
19. Das I, Khan NS, Puri BK, Sooranna SR, Debelleroche J, Hirsch SR. Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain. Biochem Biophys Res Commun 1995;212:375-380
20. Bernstein HG, Stanarius B, Baumann B, Henning H, Krell D, Danos P, et al. Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 1998;83:867-875
21. Das I, Khan NS, Puri BK, Hirsch SR. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neuroscience 1996;215:209-211
22. Bernstein HG, Bogerts B, Keilhoff G. The many faces of nitric oxide in schizophrenia. A review. Schizophrenia Res 2005; 78:69-86.
23. Yilmaz N, Herken H, Cicek HK, Celik A, Yurekli M, Akyol O. Increased levels of nitric oxide, cortisol and adrenomedullin in patients with chronic schizophrenia. Med Princ Pract 2007;16:137-141
24. Lee BH, Kim YK. Reduced plasma nitric oxide metabolites before and after antipsychotic treatment in patients with schizophrenia compared to controls. Schizophr Res 2008;104:36-43.
25. Suzuki E, Nakaki T, Nakamura M, Miyaoka H. Plasma nitrate levels in deficit versus non-deficit forms of schizophrenia. J Psychiatry Neurosci 2003;28:288-292
26. Bai O, Wei Z, Lu W, Bowen R, Keegan D, Li XM. Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. J Neurosci Res 2002;69:278-283
27. Qing H, Xu H, Wei Z, Gibson K, Li XM. The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPPq-induced apoptosis. Eur J Neurosci 2003;7: 1563-1570
28. Kremeyer B, Garcia J, Kymalainen H, Wratten N, Restrepo G, Palcio C, et al. Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. Hum Hered 2009;67:163-173
29. Wratten NS, Memoli H, Huang Y, Dulencin AM, Matteson PG, Cornacchia MA, et al. Identification of a schizophrenia-associated functional noncoding vatiant in NOS1AP. Am J Psychiatry 2009;166:434-441
30. Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, et al. A neuronal nitric oxide synthase (NOS-I) haplotype asociated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 2006;11:286-300.
31. Sastry PS, Rao KS. Apoptosis and the nervous system. J Neurochem 2000;74:1-20.
32. Uehara T, Kikuchi Y, Nomura Y. Caspase activation accompanying cytochrome C release from mitochondria is possibly involved in nitric oxide-induced neuronal apoptosis in SHSY5Y Cells. Neurochem 1999;72:196-205.
33. Tamatani M, Ogawa S, Niitsu Y, Tohyama M. Involvement of Bcl-2 family and caspase-3-like protease in NO-mediated neuronal apoptosis. J Neurochem 1998;71:1588-1596
34. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA. Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:846-858
35. Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry 2000;48:641-650
36. Jarskog LF, Selinger ES, Lieberman JA, Gilmore JH. Apoptotic proteins in the temporal cortex in schizophrenia: high Bax/Bcl- 2 ratio without caspase-3 activation. Am J Psychiatry 2004; 161:109-115